表紙
市場調查報告書
商品編碼
1028232

營養基因學市場:現狀分析與預測(2021年∼2027年)

Nutrigenomics Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

所謂營養基因學,是檢查DNA和遺傳基因,提供特別必要的營養素和飲食,醫療保健服務的科學領域。營養基因學市場,由於基因學和分子生物學的進步而發展。營養基因學企業提供戶到戶的服務,今後預計加速引進。

本報告提供全球營養基因學市場調查,市場概要,各產品、技術、用途、地區的詳細趨勢,前幾名Start-Ups企業,新型冠狀病毒感染疾病(COVID-19)的影響,收益趨勢,市場成長要素及課題,市場機會,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 調查範圍

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 營養基因學產業前幾名Start-Ups企業

第6章 新型冠狀病毒感染疾病(COVID-19)的影響

第7章 全球營養基因學市場收益額

第8章 全球營養基因學市場洞察:各產品

  • 試劑、套件
  • 服務

第9章 全球營養基因學市場洞察:各技術

  • 唾液
  • 臉頰方面拭子
  • 其他

第10章 全球營養基因學市場洞察:各用途

  • 肥胖
  • 心血管障礙(CVD)
  • 糖尿病
  • 老化防止
  • 癌症研究
  • 其他

第11章 全球營養基因學市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 其他地區

第12章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第13章 相關法規

第14章 需求與供給側面分析

  • 需求面分析
  • 供給側面分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 合併、收購

第15章 價值鏈分析

第16章 市場機會

第17章 市場趨勢 & 見解

第18章 競爭模式

  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 競爭企業間的敵對關係
    • 替代品的威脅
    • 新加入業者的威脅

第19章 企業概要

  • Unilever Group
    • 基本資料
    • 營業內容
    • 主要的產品/服務
    • 成長策略
    • SWOT分析
    • 財務資訊
    • 近幾年趨勢
  • WellGen Inc.
  • DSM
  • Metagenics Inc.
  • Nutrigenomix Inc.
  • GX Sciences Inc.
  • BASF SE
  • GX Sciences Inc.
  • Danone
  • Xcode Life

第20章 免責聲明

目錄
Product Code: UMHE21359

Nutrigenomics is a science which comprises testing the DNA and gene samples of entities so that they can be delivered with specially required nutrients, diet and healthcare services. The nutrigenomics market progression is likely to benefit from increasing advances in genomics and molecular biology. The prominent nutrigenomics firms in developed and developing nations provide door to door services, is expected to accelerate the adoption of nutrigenomics during the forecast period. For instance, in July 2019, Nutrigenomix, a global leader in genetic testing for personalized nutrition, had announced the introduction of a detailed dietary analysis and validated online nutrition assessment tool as part of its genetic testing service for healthcare experts and their clients. With this agreement, Nutrigenomix became the first and foremost testing company globally to provide a comprehensive assessment tool to supplement several of its current products and services.

The models of personalized nutrition and precision nutrition permit researchers and nutrition practitioners to tailor individual nutrition necessities better. Nutrigenomics applies many integrative methods concerning high-throughput "omics" technologies such as genomics, transcriptomics, proteomics, metabolomics, metagenomics, and epigenomics. Each analytic platform provides corresponding information that needs to be integrated suitably to achieve a better understanding of the mechanisms underlying nutrition and health. Further the rising heights of research & developments to prevent cases of cancer globally acts as a market driver. For instance, according to the American Cancer Society, In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Further, proper diet nutrition on an individual level may decrease the susceptibility of cancer and hence results in boosting the overall market.

Some of the factors which can hamper the growth of this market include necessity of skilled professionals and physicians to exploit this technology, high cost of treatment with time consuming process, budget limitations for research purposes, and requirement of large investment and resources for the execution of this method will hinder the growth of nutrigenomics market in the forecast period

Since the World Health Organization (WHO) announced that Covid-19 had become a global pandemic, and it has affected almost all the sectors of the market, so it affected the nutrigenomics market as well. But due to increasing cases of Covid 19 most of the population changed their lifestyle and eating habits to adherence with the Mediterranean Diet pattern during the COVID-19 lockdown. For instance, according to a study of PubMed, in June 2020, the perception of weight gain was observed in 48.6% of the population; 3.3% of smokers decided to quit smoking; a slight increased physical activity has been reported, especially for bodyweight training, in 38.3% of respondents; the population group aged 18-30 years resulted in having a higher adherence to the Mediterranean diet when compared to the younger and the elderly population; 15% of respondents turned to farmers or organic, purchasing fruits and vegetables, especially in the North and Center of Italy, where BMI values were lower.

Based on product, the market is bifurcated into reagents & kits and services. The reagents & kits segment grabbed the major market in 2020 due to the surge in demand for ancestry testing, with the use of cheek swabs or saliva DNA test kits, especially in the regions like Europe and North America. For instance, according to the data given by the MIT Institute and Technology, more than 26 million customers had added their respective DNA to four major health databases and commercial ancestry

Based on technique, the market is bifurcated into saliva, buccal swab, blood and others. The saliva segment ruled the major market and accounted for the maximum share in 2020 due to the increasing use of saliva samples for DNA testing globally. This has positively influenced the segment demand in the industry. The healthcare experts collect saliva samples to analyze DNA for genetic variations that affect food and beverage

Based on application, the market is bifurcated into obesity, cardiovascular disorders, diabetes, anti-aging, cancer research, and others. The obesity segment grabbed the major market in 2020 and accounted for the maximum revenue during the forecast period. The increasing obese population is due to the rise in prevalence of lifestyle and eating habits of the population. Further, the nutrigenomics helps in understanding the population on individual gene level and as per the genes, proper nutritious diet will promote reduction in obesity. This innovative approach of nutrigenomics helps in the effective prevention and treatment of diseases and is the key driving factor boosting the growth of this segment. 

For a better understanding of the market adoption of nutrigenomics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of APAC), and Rest of World. North America constitutes a major market for nutrigenomics and generated maximum revenue in 2020 owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled professionals and physicians.

Moreover, the increasing incidences of cancer, diabetes and obesity are also propelling the nutrigenomics market in this region. For instance, according to Centers for Disease Control and Prevention, 2020, the obesity rates for men are highest for middle-income groups and All the U.S. states and territories have an obesity rate of at least 20%.

Some of the major players operating in the market include: Unilever Group, WellGen Inc., DSM, Metagenics Inc., Nutrigenomix Inc., GX Sciences Inc., BASF SE, Cura Integrative Medicine, Danone, Xcode Life, etc. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions

The Nutrigenomics Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021F to 2027F. The Nutrigenomics Market is expected to witness a boost on account of increasing demand of people towards personalized nutrition and growing diabetic and obese patients across the globe. Also, the rising collaborations between the key industry players will boost the growth of nutrigenomics market

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Nutrigenomics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Nutrigenomics Market
    • 2.1.1 Main Objective of the Global Nutrigenomics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER NUTRIGENOMICS INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL NUTRIGENOMICS MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

  • 8.1 Reagents & Kits
  • 8.2 Services

9 MARKET INSIGHTS BY TECHNIQUE

  • 9.1 Saliva
  • 9.2 Buccal Swab
  • 9.3 Blood
  • 9.4 Others

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Obesity
  • 10.2 Cardiovascular Disorders (CVD)
  • 10.3 Diabetes
  • 10.4 Anti-Aging
  • 10.5 Cancer Research
  • 10.6 Others

11 MARKET INSIGHTS BY REGION

  • 11.1 NORTH AMERICA NUTRIGENOMICS MARKET
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Rest of North America
  • 11.2 EUROPE NUTRIGENOMICS MARKET
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 United Kingdom
    • 11.2.4 Spain
    • 11.2.5 Italy
    • 11.2.6 Rest of Europe
  • 11.3 ASIA PACIFIC NITRIGENOMICS MARKET
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Australia
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia Pacific
  • 11.4 REST OF THE WORLD NUTRIGENOMICS MARKET

12 NUTRIGENOMICS MARKET DYNAMICS

  • 12.1 Market Drivers
  • 12.2 Market Challenges
  • 12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis
    • 14.2.1 Top Product Launches
    • 14.2.2 Top Business Partnerships
    • 14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 NUTRIGENOMICS MARKET OPPORTUNITIES

17 NUTRIGENOMICS MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1 Porter's Five forces analysis
    • 18.1.1 Bargaining power of Supplier
    • 18.1.2 Bargaining power of Buyer
    • 18.1.3 Industry Rivalry
    • 18.1.4 Availability of Substitute
    • 18.1.5 Threat of new Entrants

19 COMPANY PROFILED

  • 19.1   Unilever Group
    • 19.1.1 Key Facts
    • 19.1.2 Business Description
    • 19.1.3 Key Product/Services Offerings
    • 19.1.4 Growth Strategy
    • 19.1.5 SWOT Analysis
    • 19.1.6 Key Financials
      • 19.1.6.1 Revenue Split
      • 19.1.6.2 Financial Overview of Unilever Group
    • 19.1.7 Recent Developments
      • 19.1.7.1 Product Launch
      • 19.1.7.2 Partnerships
      • 19.1.7.3 Business Expansion and Investments
      • 19.1.7.4 Merger and Acquisition
  • 19.2 WellGen Inc.
  • 19.3 DSM
  • 19.4 Metagenics Inc.
  • 19.5 Nutrigenomix Inc.
  • 19.6 GX Sciences Inc.
  • 19.7 BASF SE
  • 19.8 GX Sciences Inc.
  • 19.9 Danone
  • 19.10 Xcode Life

20 DISCLAIMER